Rezolute, Inc.
RZLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001509261
No open-market purchases or sales by Rezolute, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $450.3M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Rezolute, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +1 vs. Q1 2021
- Shares held
- 2.21M
- −265.5K (−10.7%) vs. Q1 2021
- Total value
- $31.6M
- +$14.1M (+80.5%) vs. Q1 2021
- New holders
- 5
- 1 more added
- Sold out
- 4
- 2 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RZLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 144 | $450.3M |
| Q1 2026 | 125 | $263.2M |
| Q4 2025 | 122 | $213.4M |
| Q3 2025 | 116 | $817.1M |
| Q2 2025 | 92 | $347.5M |
| Q1 2025 | 77 | $130.6M |
| Q4 2024 | 71 | $211.7M |
| Q3 2024 | 59 | $186.9M |
| Q2 2024 | 52 | $170.0M |
| Q1 2024 | 33 | $69.0M |
| Q4 2023 | 32 | $28.7M |
| Q3 2023 | 30 | $31.5M |
| Q2 2023 | 29 | $48.0M |
| Q1 2023 | 32 | $46.5M |
| Q4 2022 | 34 | $50.6M |
| Q3 2022 | 33 | $67.0M |
| Q2 2022 | 35 | $79.2M |
| Q1 2022 | 21 | $24.0M |
| Q4 2021 | 23 | $36.0M |
| Q3 2021 | 14 | $17.6M |
| Q2 2021 | 12 | $31.6M |
| Q1 2021 | 11 | $17.5M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Rezolute, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 1,212,122 | $17.3M | 0.03% | 00.0% | Unchanged |
| Caxton Corp | 424,243 | $6.05M | 4.15% | 00.0% | Unchanged |
| Citadel Advisors LLC | 307,988 | $4.39M | 0.00% | −4,348−1.4% | Reduced |
| BVF Inc | 190,815 | $2.72M | 0.10% | 00.0% | Unchanged |
| Northern Trust Corp | 32,124 | $459.0K | 0.00% | +32,124 | New |
| Vanguard Group Inc | 29,390 | $419.0K | 0.00% | +29,390 | New |
| BlackRock Inc. | 12,430 | $177.0K | 0.00% | +12,430 | New |
| UBS Group AG | 918 | $13.0K | 0.00% | +334+57.2% | Added |
| The PNC Financial Services Group, Inc. | 750 | $11.0K | 0.00% | +750 | New |
| Tower Research Capital LLC (TRC) | 647 | $9.00K | 0.00% | −1,964−75.2% | Reduced |
| Advisor Group Holdings, Inc. | 65 | $1.00K | 0.00% | +65 | New |
| Morgan Stanley | 21 | $0 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −288,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −26,924−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −18,916−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −475−100.0% | Sold out |